Live
WatersTranscript : Waters Corporation Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 10 - marketscreener.comEndpoints NewsWhat it will take for more employer GLP-1 coverageBioPharma DiveHouse bill aims to crack down on China biotech dealsBioPharma DiveNewLimit’s $435M megaround; Lilly’s busy dealmaking weekLonza NewsLonza Enhances Biologics Preclinical Development Offering - Contract PharmaLabiotechHighlights of ASCO 2026: how is cancer care evolving?Clinical OMICsExperienced Physicians Still Beat AI at Skin Cancer DiagnosisEndpoints NewsRegeneron doubles down on CytomX after other pharmas walked awayClinical OMICsArthur Caplan: The Right to Life, Liberty, and Pursuit of HealthEndpoints NewsMineralys makes money moves before looming hypertension approvalFierceBiotechRegeneron pays $37M, adds $2B in biobucks to expand CytomX pactPharmaVoiceWhen the ISS comes down, will its drug R&D be lost in space?
FierceBiotech Mar 3, 2026

New cancer cases prompt Kyowa to discontinue late-stage autoimmune disease program

New cancer cases prompt Kyowa to discontinue late-stage autoimmune disease program

Original
Body unavailable. Use the original source.